$995 Million is the total value of HealthCor Management, L.P.'s 58 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HOLX | New | HOLOGIC INC | $27,866,000 | – | 402,110 | +100.0% | 2.80% | – |
| CI | New | CIGNA CORP NEW | $25,422,000 | – | 96,470 | +100.0% | 2.56% | – |
| LLY | New | LILLY ELI & CO | $22,900,000 | – | 70,630 | +100.0% | 2.30% | – |
| BSX | New | BOSTON SCIENTIFIC CORPcall | $18,635,000 | – | 500,000 | +100.0% | 1.87% | – |
| SGEN | New | SEAGEN INC | $18,235,000 | – | 103,060 | +100.0% | 1.83% | – |
| A | New | AGILENT TECHNOLOGIES INC | $16,424,000 | – | 138,280 | +100.0% | 1.65% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $14,549,000 | – | 72,490 | +100.0% | 1.46% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $10,006,000 | – | 1,209,880 | +100.0% | 1.01% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $7,566,000 | – | 72,020 | +100.0% | 0.76% | – |
| DXCM | New | DEXCOM INC | $5,573,000 | – | 74,780 | +100.0% | 0.56% | – |
| XLV | New | SELECT SECTOR SPDR TRsbi healthcare | $4,438,000 | – | 34,610 | +100.0% | 0.45% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $3,757,000 | – | 499,640 | +100.0% | 0.38% | – |
| CCXI | New | CHEMOCENTRYX INCcall | $2,478,000 | – | 100,000 | +100.0% | 0.25% | – |
| ALGN | New | ALIGN TECHNOLOGY INCcall | $2,367,000 | – | 10,000 | +100.0% | 0.24% | – |
| PODD | New | INSULET CORP | $1,558,000 | – | 7,150 | +100.0% | 0.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.